Nektar Therapeutics

NASDAQ: NKTR
$1.35
-$0.05 (-3.2%)
Real Time Data Delayed 15 Min.

NKTR Stock Chart and Intraday Price

NKTR Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, US
Fiscal Year End December
Latest Quarter 9/30/2023
Market Cap 148.80M USD
Shares Outstanding 190,771,000
Nektar Therapeutics is a biopharmaceutical firm based in San Francisco, focusing on creating innovative medicines in immunotherapy. The company is working on treatments for a range of conditions, including systemic lupus erythematosus, ulcerative colitis, atopic dermatitis, psoriasis, non-Hodgkin’s lymphoma, multiple myeloma, and various cancers. With a strong commitment to advancing healthcare, Nektar Therapeutics collaborates with leading pharmaceutical companies worldwide to bring new therapies to patients in need.

NKTR Articles

Thursday's top analyst upgrades and downgrades included Airbnb, Alcon, Antero Midstream, Exact Sciences, GitLab, GlobalFoundries, Halozyme Therapeutics, Lumentum, Nektar Therapeutics, PayPal and...
Monday's additional top analyst upgrades and downgrades were on Coinbase Global, Global Blood Therapeutics, Grab, Leslie’s, Nektar Therapeutics, Park Hotels & Resorts, Rocket Companies and Roku.
Tuesday’s additional top analyst upgrades and downgrades included Dow, Estee Lauder, Magellan Midstream Partners, Nektar Therapeutics, Novo Nordisk, Rocket Companies, Sherwin-Williams, Steel...
Monday’s additional top analyst upgrades and downgrades included Aptiv, BioCryst Pharmaceuticals, CSX, Gap, Nektar Therapeutics, Progressive, Peloton Interactive, Sirius XM and United Airlines.
Tuesday afternoon's top analyst upgrades and downgrades included Coupa Software, GoodRx, Mosaic and Nektar Therapeutics.
Wednesday afternoon's top analyst upgrades and downgrades included Bumble, Coupang, Foot Locker, Gap, Match, Nektar Therapeutics, Paychex, Signify Health and Stitch Fix.
Tuesday’s top analyst upgrades and downgrades included Bloomin' Brands, Boston Beer, Bumble, Goldman Sachs, Juniper Networks, Merck, Moderna, Petco Health, Southern Company, Spirit Airlines and...
Tuesday's top analyst upgrades and downgrades included Airbnb, Canopy Growth, Continental Resources, DraftKings, Fisker, Moderna, Owens Corning, SunPower and Wayfair.
Friday’s top analyst upgrades and downgrades included American Tower, Best Buy, Beyond Meat, Editas Medicine, Freeport McMoRan, First Solar and UnitedHealth.
Monday’s top analyst upgrades and downgrades included GoDaddy, Groupon, Resmed, Salesforce, Shopify, Squarespace, Yelp, and more.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Tuesday, including BioNTech, Denali Therapeutics, Exelixis, Foot Locker and Hostess Brands.
Monday's top analyst upgrades and downgrades included Alphabet, Amazon.com, Amgen, Cerner, eBay, Gap, Nike, Nucor, Procter & Gamble, TJX and ViacomCBS.
Wednesday's top analyst upgrades, downgrades and initiations included Altria, Beyond Meat, Chevron, Chipotle Mexican Grill, Epizyme, FedEx, Home Depot, Mattel, Morgan Stanley, Oracle, Qualcomm and...
Monday's top analyst upgrades, downgrades and initiations included Aimmune Therapeutics, Amgen, Biogen, Chevron, CRISPR, Exxon Mobil, Nike, Snap, Uber, Ulta Beauty and Verizon.
This past week played host to a huge number of biotech movers. 24/7 Wall St. has picked a few of these standouts to highlight.